SpotLight

On 19 May 2023, FDA approved Abbvie-Genmab’s EPKINLY, as the first CD20XCD3 bispecific antibody R/R DLBCL treatment in adults.

Chondrosarcoma is a group of bone tumors made up of cells that make too much cartilage. As per DelveInsight analysis, the total incident cases of chondrosarcoma in the 7MM comprised approximately 2,331 cases in 2022 and are projected to increase during the forecasted period. Our estimates suggest that the United St...

The discovery of cell and gene therapies has opened up new possibilities for the treatment of rare diseases, especially in Japanese population

Despite many clinically failed attempts, GSK finally set to launch RSVPreF3, the first preventive respiratory syncytial virus vaccine.

Cancer is a global burden, leading to a significant number of death and disabilities worldwide. In 2020, nearly one in six deaths were related to cancer. Breast cancer, lung cancer, colon and rectum cancer, and prostate cancer are some of the major cancer types, registering the highest number of cases globally. To ...

The future of diabetes treatment is changing, as several companies are working on new treatment options for type 1 and type 2 diabetes.

Recent approvals of ADCs for DLBCL treatment, such as Roche's POLIVY & ADC Therapeutics' ZYNLONTA, given patients & physicians renewed hope.

Physiotherapy, also called physical therapy, is critical in providing holistic treatment for various disorders, injuries, and diseases. It improves mobility, strength, balance, and coordination. Especially in the case of injury, or chronic pain, it can have a long-lasting impact and greatly help manage the symptoms...

Bronchiectasis is a chronic respiratory condition where the bronchial tubes in the lungs become damaged, inflamed, and widened, leading to a buildup of mucus that makes breathing difficult. The condition can develop for various reasons, including infections, genetic disorders, autoimmune conditions, and other facto...

To address challenges, pharma giants GSK & Pfizer are bringing first vaccine for respiratory syncytial virus treatment to adult population.